Your browser doesn't support javascript.
loading
Concomitant symptomatic cardiac sarcoidosis and systemic sclerosis with cardiac involvement: a case report.
Lemay, Sylvain; Jeantin, Carla; Kyomi Labelle, Frédérique; Philippon, François; Beaudoin, Jonathan; Albert, Alexandra; Dion, Geneviève; Trottier, Mikaël; Dubois, Michelle; Charbonneau, Éric; Gleeton, Guylaine; Massé, Charles; Raymond, Cédric; Birnie, David H; Sénéchal, Mario.
Afiliação
  • Lemay S; Department of Cardiology, Institut Universitaire de Cardiologie et de Pneumologie de Québec, Laval University Québec, Canada.
  • Jeantin C; Department of Cardiology, Institut Universitaire de Cardiologie et de Pneumologie de Québec, Laval University Québec, Canada.
  • Kyomi Labelle F; Department of Cardiology, Institut Universitaire de Cardiologie et de Pneumologie de Québec, Laval University Québec, Canada.
  • Philippon F; Department of Cardiology, Institut Universitaire de Cardiologie et de Pneumologie de Québec, Laval University Québec, Canada.
  • Beaudoin J; Department of Cardiology, Institut Universitaire de Cardiologie et de Pneumologie de Québec, Laval University Québec, Canada.
  • Albert A; Department of Rheumatology, Institut Universitaire de Cardiologie et de Pneumologie de Québec, Laval University Québec, Canada.
  • Dion G; Department of Pneumology, Institut Universitaire de Cardiologie et de Pneumologie de Québec, Laval University Québec, Canada.
  • Trottier M; Department of Nuclear Medicine, Institut Universitaire de Cardiologie et de Pneumologie de Québec, Laval University Québec, Canada.
  • Dubois M; Research Center, Institut Universitaire de Cardiologie et de Pneumologie de Québec, Laval University Québec, Canada.
  • Charbonneau É; Department of Cardiac Surgery, Institut Universitaire de Cardiologie et de Pneumologie de Québec, Laval University Québec, Canada.
  • Gleeton G; Department of Radiology, Institut Universitaire de Cardiologie et de Pneumologie de Québec, Laval University Québec, Canada.
  • Massé C; Research Center, Institut Universitaire de Cardiologie et de Pneumologie de Québec, Laval University Québec, Canada.
  • Raymond C; Research Center, Institut Universitaire de Cardiologie et de Pneumologie de Québec, Laval University Québec, Canada.
  • Birnie DH; Department of Cardiology, University of Ottawa Heart Institute Ottawa, Ontario, Canada.
  • Sénéchal M; Department of Cardiology, Institut Universitaire de Cardiologie et de Pneumologie de Québec, Laval University Québec, Canada.
Am J Cardiovasc Dis ; 13(4): 283-290, 2023.
Article em En | MEDLINE | ID: mdl-37736350
ABSTRACT
Sarcoidosis and systemic sclerosis are two inflammatory multisystemic disorders of unknown etiology that may be life-threatening especially when there is cardiac involvement. Both diseases may coexist, however, there are very few case reports of patients with both cardiac sarcoidosis and systemic sclerosis in the literature. We report the case of a 72-year-old female who was initially referred for dyspnea. A chest computed tomography scan showed multiple hilar and mediastinal adenopathy with a non-specific opacity in the middle pulmonary lobe. FDG-PET-scan showed increased FDG uptake in the adenopathy, the middle lobe and the right ventricular free wall. Sarcoidosis was confirmed with a lung biopsy. Both electrocardiogram and echocardiogram were normal. Four months later, the patient developed a high-grade atrioventricular block deemed secondary to her cardiac sarcoidosis. Two years later, the patient was referred to a rheumatologist for severe Raynaud's symptoms, sclerodactyly and acrocyanosis. After thorough investigations, a diagnosis of limited cutaneous systemic sclerosis with systemic and cardiac sarcoidosis was made. This case demonstrates that both cardiac sarcoidosis and systemic sclerosis may coexist. In the literature, either disease may come first. In cases where cardiac symptoms appear after the diagnosis of concomitant sarcoidosis and systemic sclerosis, it might be difficult for clinicians to confirm which disease is responsible for the heart involvement. This is important since early cardiac sarcoidosis treatment should be done to prevent major complications and may well differ from systemic sclerosis treatment. In this review, we discuss the main clinical manifestations and imaging findings seen with cardiac disease secondary to sarcoidosis and systemic sclerosis.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies Idioma: En Revista: Am J Cardiovasc Dis Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Canadá

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies Idioma: En Revista: Am J Cardiovasc Dis Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Canadá